Analysen von Jack Scannell
| 26.04.19 | Sanofi Neutral | UBS AG | |
| 04.03.19 | Novartis Neutral | UBS AG | |
| 04.03.19 | Roche Neutral | UBS AG | |
| 25.02.19 | Roche Neutral | UBS AG | |
| 13.02.19 | Roche Neutral | UBS AG | |
| 07.02.19 | Sanofi Neutral | UBS AG | |
| 31.01.19 | Roche Neutral | UBS AG | |
| 30.01.19 | Roche Neutral | UBS AG | |
|
Werbung
|
|||
| 10.12.18 | Roche Neutral | UBS AG | |
| 28.11.18 | Sanofi Neutral | UBS AG | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 31.10.18 | Sanofi Neutral | UBS AG | |
| 23.10.18 | Roche Neutral | UBS AG | |
| 17.10.18 | Roche Neutral | UBS AG | |
| 25.09.18 | AstraZeneca Neutral | UBS AG | |
| 14.09.18 | Roche Neutral | UBS AG | |
| 30.07.18 | AstraZeneca Neutral | UBS AG | |
| 26.07.18 | Roche Neutral | UBS AG | |
| 26.07.18 | AstraZeneca Neutral | UBS AG | |
| 02.07.18 | AstraZeneca Neutral | UBS AG | |
| 26.06.18 | Roche Neutral | UBS AG | |
| 25.06.18 | AstraZeneca Neutral | UBS AG | |
| 18.05.18 | Roche Neutral | UBS AG | |
| 18.05.18 | AstraZeneca Neutral | UBS AG | |
| 20.03.18 | Roche Neutral | UBS AG | |
| 02.03.18 | Sanofi Neutral | UBS AG | |
| 20.02.18 | Roche Neutral | UBS AG | |
| 06.02.18 | AstraZeneca Neutral | UBS AG | |
| 06.02.18 | Roche Neutral | UBS AG | |
| 30.01.18 | Sanofi Neutral | UBS AG | |
| 08.01.18 | Merck buy | UBS AG | |
| 08.01.18 | AstraZeneca Neutral | UBS AG | |
| 08.01.18 | Sanofi Neutral | UBS AG | |
| 08.01.18 | Roche Neutral | UBS AG | |
| 14.12.17 | Sanofi Neutral | UBS AG | |
| 08.12.17 | Roche Neutral | UBS AG | |
| 07.12.17 | Roche Neutral | UBS AG | |
| 06.12.17 | Roche Neutral | UBS AG | |
| 09.11.17 | AstraZeneca Neutral | UBS AG | |
| 23.10.17 | Bayer buy | UBS AG | |
| 23.10.17 | AstraZeneca Neutral | UBS AG | |
| 23.10.17 | GSK Neutral | UBS AG | |
| 23.10.17 | Merck buy | UBS AG | |
| 23.10.17 | Sanofi Neutral | UBS AG | |
| 23.10.17 | Roche Neutral | UBS AG | |
| 23.10.17 | Novo Nordisk buy | UBS AG | |
| 23.10.17 | Novartis Neutral | UBS AG | |
| 19.10.17 | Roche Neutral | UBS AG | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |